Purpose: Frailty is a clinically recognised syndrome of decreased physiological reserve. The heightened state of vulnerability in these patients confers a greater risk of adverse outcomes after various procedures. Our aim was to assess the prevalence and prognostic significance of the frailty phenotype in patients referred for lung transplantation (LTx). Methods: Consecutive patients referred or on the waiting list for LTx from March 2013 underwent frailty assessment. Frailty was defined as a positive response to three or more of the following five components; weak grip strength, slowed walking speed, poor appetite, physical inactivity and exhaustion. In addition, markers of disease severity were obtained and all patients underwent cognitive (Montreal Cognitive Assessment, MoCA) and depression (Depression in Medical Illness, DMI-10) screening. Results: 168 patients (85M:83F), (age 49 + 15 years, range 16-70) underwent frailty assessment. 30/168 (18%) were assessed as frail. Frailty was associated with lower hemoglobin and serum albumin, cognitive impairment and depression (all ρ < 0.05). Frailty was independent of age, gender, underlying cause of lung disease, measures of pulmonary dysfunction (hypoxemia, % predicted FEV1 or DLCO/VA) or renal function. Frailty was an independent predictor of increased all-cause mortality. 1-year actuarial survival was 95 + 2% in the non-frail group compared with 77 + 8% for the frail group (p< 0.001). Conclusion: Frailty is prevalent among patients with advanced lung disease referred for lung transplantation and is associated with increased mortality.
Purpose: Currently the assessment process examines the patient's physical capabilities, support network and commitment to the transplant process. Amidst our ever aging population more complex patients are being referred and the need to examine the prevalence of frailty has arisen. This might allow us to target specific therapies to individuals who are in need of special attention.
Conclusion:
A BMI higher than 30 kg / m2 is a risk factor of PGD in lung transplantation. The BMI is potentially modifiable and should be decrease prior to transplant aimed at improving lung transplant results. Purpose: Frailty is defined as an increased susceptibility to adverse health outcomes. Pre-transplant frailty is an independent predictor of mortality following lung transplantation. The impact of frailty on other important transplant outcomes is unknown. The objective of this study was to evaluate the impact of pre-transplant frailty on hospital readmissions, opportunistic infections, and acute rejection episodes in the first year following lung transplant.
Methods:
We conducted a single-center, retrospective cohort review of all adult patient undergoing lung transplantation from 2002-13. Frailty was assessed using the frailty deficit index, a validated measurement of frailty that measures the proportion of deficits present among 32 impairments, disabilities, and comorbidities with a score ≥ 0.25 considered frail. Medical records were abstracted for readmissions, acute rejection, and opportunistic infections in the first year. Bronchoscopic biopsies were scheduled at 1-, 3-, and 6-months by protocol and as clinically indicated. Results: Out of 144 lung transplant patients, 102 (71%) completed selfreported questionnaires necessary to assess frailty. Hospital readmission data was available on 95 patients. The proportion of patients who had 4 or more hospital admissions after transplant was increased in frail compared to non-frail patients (46.4% versus 14.9%, p= 0.027). The median (interquartile range) number of hospital readmissions was 2 (0-4) for frail patients compared to 1 (0-3) for not frail patients, p = 0.035. The proportion of patients who had severe acute rejection after lung transplant was increased in frail patients compared to non-frail patients (0.08% versus 0%, p= 0.030). There was no difference in the rates of mild or moderate acute rejection. Conclusion: Patients with pre-transplant frailty, as measured by the frailty deficit index, had higher rates of hospital readmissions and severe acute rejection in the first year following lung transplant compared to non-frail patients.
